Abliva AB (publ) (ABLI.ST)

SEK 0.42

(-0.83%)

Eps Summary of Abliva AB (publ)

  • Abliva AB (publ)'s latest annual eps in 2023 was -0.09 SEK , up 17.82% from previous year.
  • Abliva AB (publ)'s latest quarterly eps in 2024 Q2 was -0.02 SEK , down -18.6% from previous quarter.
  • Abliva AB (publ) reported an annual eps of -0.11 SEK in 2022, up 66.67% from previous year.
  • Abliva AB (publ) reported an annual eps of -0.33 SEK in 2021, down -43.48% from previous year.
  • Abliva AB (publ) reported a quarterly eps of -0.02 SEK for 2024 Q1, up 28.03% from previous quarter.
  • Abliva AB (publ) reported a quarterly eps of -0.02 SEK for 2023 Q2, down -33.77% from previous quarter.

Annual Eps Chart of Abliva AB (publ) (2023 - 2007)

Historical Annual Eps of Abliva AB (publ) (2023 - 2007)

Year Eps Eps Growth
2023 -0.09 SEK 17.82%
2022 -0.11 SEK 66.67%
2021 -0.33 SEK -43.48%
2020 -0.23 SEK 47.73%
2019 -0.44 SEK 49.43%
2018 -0.87 SEK 25.64%
2017 -1.17 SEK 11.36%
2016 -1.32 SEK 43.1%
2015 -2.32 SEK -88.62%
2014 -1.23 SEK -41.38%
2013 -0.87 SEK -35.94%
2012 -0.64 SEK -45.45%
2011 -0.44 SEK -91.3%
2010 -0.23 SEK -219.44%
2009 -0.07 SEK 6.86%
2008 -0.08 SEK -33.97%
2007 -0.06 SEK 0.0%

Peer Eps Comparison of Abliva AB (publ)

Name Eps Eps Difference
Alligator Bioscience AB (publ) -0.55 SEK 83.564%
Ziccum AB (publ) -1.54 SEK 94.13%
Modus Therapeutics Holding AB (publ) -1.01 SEK 91.05%
BioArctic AB (publ) 2.60 SEK 103.477%
Sprint Bioscience AB (publ) -0.01 SEK -1334.921%
Mendus AB (publ) -4.40 SEK 97.945%
Genovis AB (publ.) 0.94 SEK 109.617%
Intervacc AB (publ) -1.69 SEK 94.651%
QuiaPEG Pharmaceuticals Holding AB (publ) -0.22 SEK 58.909%
Active Biotech AB (publ) -0.17 SEK 46.824%
Magle Chemoswed Holding AB (publ) 1.13 SEK 108.0%
Bio-Works Technologies AB (publ) -1.57 SEK 94.242%
Aptahem AB (publ) -0.05 SEK -87.164%
Vicore Pharma Holding AB (publ) -3.22 SEK 97.193%
Kancera AB (publ) -0.80 SEK 88.7%
Infant Bacterial Therapeutics AB (publ) -9.95 SEK 99.091%
Fluicell AB (publ) -0.24 SEK 62.333%
Saniona AB (publ) -1.29 SEK 92.992%
Lipigon Pharmaceuticals AB (publ) -0.19 SEK 52.421%
Biovica International AB (publ) -2.14 SEK 95.776%
Spago Nanomedical AB (publ) -0.43 SEK 78.977%
AcouSort AB (publ) -1.29 SEK 92.992%
Xintela AB (publ) -0.13 SEK 30.462%
Egetis Therapeutics AB (publ) -1.27 SEK 92.882%
Karolinska Development AB (publ) 0.02 SEK 552.0%
OncoZenge AB (publ) -1.36 SEK 93.353%
Amniotics AB (publ) -0.01 SEK -721.818%
2cureX AB (publ) -1.85 SEK 95.114%
CombiGene AB (publ) -1.80 SEK 94.978%
Asarina Pharma AB (publ) -0.57 SEK 84.14%
Calliditas Therapeutics AB (publ) -8.69 SEK 98.96%
Camurus AB (publ) 7.78 SEK 101.162%
Corline Biomedical AB -0.08 SEK -7.363%
IRLAB Therapeutics AB (publ) -3.43 SEK 97.364%
Isofol Medical AB (publ) -0.23 SEK 60.696%
I-Tech AB 1.70 SEK 105.318%
Hansa Biopharma AB (publ) -15.83 SEK 99.429%
Cyxone AB (publ) -0.22 SEK 58.909%
ExpreS2ion Biotech Holding AB (publ) -1.98 SEK 95.434%
Biosergen AB -0.60 SEK 84.933%
Cantargia AB (publ) -1.65 SEK 94.521%
NextCell Pharma AB -1.03 SEK 91.223%
Xspray Pharma AB (publ) -6.76 SEK 98.663%
Elicera Therapeutics AB (publ) -0.83 SEK 89.108%
Nanologica AB (publ) -2.05 SEK 95.59%
SynAct Pharma AB -6.64 SEK 98.639%
Annexin Pharmaceuticals AB (publ) -0.26 SEK 65.231%
Stayble Therapeutics AB (publ) -0.92 SEK 90.174%
LIDDS AB (publ) -0.63 SEK 85.651%
Lipum AB (publ) -4.45 SEK 97.969%
BioInvent International AB (publ) -5.02 SEK 98.199%
Alzinova AB (publ) -0.41 SEK 77.951%
Oncopeptides AB (publ) -1.96 SEK 95.388%
Pila Pharma AB (publ) -0.47 SEK 80.766%
Guard Therapeutics International AB (publ) -11.26 SEK 99.197%
Scandinavian ChemoTech AB (publ) -1.13 SEK 92.0%
Simris Alg AB (publ) -0.16 SEK 43.5%
Diamyd Medical AB (publ) -1.60 SEK 94.35%
Xbrane Biopharma AB (publ) -1.27 SEK 92.882%
Ascelia Pharma AB (publ) -3.24 SEK 97.21%
Diagonal Bio AB (publ) -0.32 SEK 71.75%